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Abstract 
 
Every year the US and European countries face an epidemic of organ failure from a multitude of reasons: cancer, genetic 
predisposition, exposure to harmful chemicals in home or surrounding areas or through drinking, drugs and smoking. Another 
problem faced, is the ratio of organ donors to organ recipients. Over 121,000 patients are on the waiting for an organ transplant, and a 
fraction of those waiting will die because of time. The Hanover Medical school and department of quality management, have created 
an integrated approach to organ transplant avenues. Quality management is a systematic guide for organ transplantation that allows 
all clinical trials to follow a standard operating procedure and protocol. This paper will talk about the use of integrated pathways in 
transplantation management in US/EU transplant centers. It will also discuss how quality management plays an intricate/necessary 
role in ensuring all clinical trials are efficient in organ transplantation and can meet the necessary demands of saving lives, while 
improving outcomes of transplanting vital organs. I will also discuss the gaps present in clinical research and the current research 
that’s being down to enhance the field of organ transplantation. The role of quality management is to ensure that all studies are 
performed with proper efficacy, high ethical standards, and contain a set of clear standard operating procedures and protocols for 
each clinical trial. 
  Key words: Clinical management, QMS, organ transplant 
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Problems with Clinical Research 
 
 This summer I participating in a clinical research program through the University of Hochschule Hanover of Applied Science 
and art in Germany. To complete my 300/hr. internship, I interned through the department of Quality management at the Hanover 
Medical school. The U.S public health problems that are prevalent are: Accurate assessments of alloimmunity, simultaneous 
dissemination of assays to the transplant community, which means making the screening process more thorough for detection of 
disease, international exchange of data to optimize safety and efficacy leading to increased success within the clinical pathways of 
organ transplantation, and uncovering the unmet needs of patient’s pre-transplantation, peri-transplantation & post transplantation.  
Through the internship, I focused on the use of Clinical Pathways in organ transplantation management in the U.S./EU.    
Every day on average, 22 people die while waiting for an organ transplant in the U.S and European countries. (UNOS, 2016).  
 
 The project I worked on was to see what clinical pathways are established for organ transplant management in the US/EU 
transplant centers. The purpose was to find connections in how countries acquire/transport internal organs to organ recipients 
around the world, and how the quality management can improve utilizing quality assurance and quality control within the clinical 
setting. The public health problem is organ transplantation and the continuous gap that’s increasing between organ supply and 
demand in the U.S and European countries (EU).   In 2014, there were 39,973 organ transplants performed in the U.S with a 5% 
increase from 2014 to 2015 (HRSA, 2015). There was a total of  approximately 114,690 organ transplants worldwide, of which 30.9% 
per 1000 transplants occurred in the U.S. and 25% in the European Union (EU) (HRSA, 2016). The World Health Organization (WHO) 
has issued a resolution and guiding principles in consideration thereof, particularly noting the following challenges:  The shortage of 
available organs has not only prompted many countries to develop procedures and systems to increase supply but has also 
stimulated commercial traffic in human organs, particularly from living donors who are unrelated to recipients. The evidence of such 
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commerce, along with the related traffic in human beings, has become clearer in recent decades. Moreover, the growing ease of 
international communication and travel has led many patients to travel abroad to medical centers that advertise their ability to 
perform transplants and to supply donor organs for a single, inclusive charge (WHO, 2010). Second, there is a current awareness of 
the growing magnitude and utility of human cell, tissue and organ transplantation for a wide range of conditions in low-resource as 
well as high-resource countries; A third challenge is to ensure the safety, efficacy and ethical standards are followed for each patient 
and future donor. The fourth challenge was stated in the resolutions WHA40.13 and WHA42.5 and first expressed the Health 
Assembly’s concern over commercial trade in organs and the need for global standards for transplantation. Lastly, among the most 
pressing challenges for population health researchers and clinicians is the accurate assessment of alloimmunity and simultaneous 
dissemination of assays to the transplant community are essential for post-transplantation surveillance and international exchange of 
data to optimize safety and efficacy (WHO,2010).  
 
 In response to this, a number of initiatives have been proposed, including the potential establishment of a global virtual 
laboratory, the assessment of outcomes post-transplantation, and navigation of ethical and legal considerations. Developing a GVL 
would mean disseminating detailed and rigorous protocols for the monitoring of alloimmune responses. It aims to initiate steps at 
making standardized testing methods and expertise more accessible to the global transplant research community conducting clinical 
trials (Geissler, Tullius, Chong, 2015). This will be able to implement novel transplantation strategies that can improve long-term 
outcomes (one of our current most challenging issues).  
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An integrative approach to organ transplantation 
 
A quality management system (QMS) is a formalized system that documents processes, procedures, and responsibilities for 
achieving quality policies and objectives. A QMS helps coordinate and direct clinical trial activities to meet patients and regulatory 
requirements of that hospital and improve its effectiveness and efficiency on a continuous basis.  The department of quality 
management in Hanover Germany, created an avenue for an integrative approach to organ transplantation and how it can increase 
success in organ treatment. Their purpose is reducing loss of organs, increase long-term success/results and increase the amount of 
time an organ be en route to a patient in need (ASQ, 2015). The diagram below shows an integrative approach to organ transplant 
avenues for organ transplantation, as well as, how other areas can contribute to the success of 1 of 5 main branches. 
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Quality management allows continuous improvement in quality control, as well as, quality assurance of all clinical trials performed in 
Germany. Germany has begun creating an integrative approach using quality management control within organ transplantation 
systems. The QMS helps provide a systematic guide in the development of a robust system for reporting, investigating and resolving 
all errors, accidents, adverse events and biological product deviations and complaints. This will ensure the “process” that is at fault or 
having errors be fixed because it will be one of the most important aspects of safety in transplantation. Clinical research will have 
more opportunities in achieving optimal success with having quality management oversight in all avenues (ASQ,2015). 
 
One of the benefits of developing and implementing a QMP includes developing proactive communication among clinical trial 
team members.  This benefits clinical trial teams by encouraging early identification and resolution of clinical trial problems and 
concerns. Implementing a Clinical Trial QMP can also encourage conformity with Standard Operating Procedure, Good Clinical 
Practice (GCP), Good Laboratory Practice, and UCSF policies and procedures.  This leads to an overall reduction in external 
(Sponsor, FDA) and internal (UCSF) data queries, and helps reduce clinical trial closeout time (UCSF, 2015).  All transplant related 
procedures are subject to continuous review and improvement. If certain parts of the services provided by the transplant center are to 
be amended significantly or a new field of procedure are developed, a new plan of development should be compiled and released by 
the medical program director. This is the purpose of why quality management is a part of clinical research trials; it will provide access 
to more reliable data/statistics, ensure ethical protocols are followed, monitor and measure the process and service 
 
Another important aspect while working on integrative pathways in organ transplantation, is the transportation and allocation 
for each organ. The purpose of this project was to find ways to increase the preservation time of each organ by creating new 
techniques to store/transfer. Organ preservation remains an important contributing factor to graft and patient outcomes (Latchana, 
Peck, Whitson, Henry, 2015). Today’s Current Standard of Care: The Picnic Cooler vs. OTS’ Revolutionary Technology: The 
LifeCradle® Heart Perfusion System (OTS, 2012). Both techniques are in use and under review of which one will be able to preserve 
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the organ the longest, which will give more flexibility with allocation of the organ. Focusing on preservation solutions represents one 
potential avenue to improve patient and graft outcomes in transplantation and may be an effective strategy to decrease healthcare costs 
associated with transplantation (Latchana, Peck, Whitson, Henry, 2015).  
 
Shown below is a table that provides an example of treatment avenues and what qualifies a patient to receive an organ 
transplant (i.e. diagnosis), and how to measure outcomes/patient survival. Measuring outcomes is extremely essential to measuring 
success of treatment post-transplantation. Organ failure typically begins one-year post-operation, which is why quality management 
control is an important avenue in organ transplant research.  
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Organs Dx receiving transplant Tolerance: measuring 
outcomes 
In/out PT survival % of 
transplants 
done 
U.S or 
EU 
Heart CHD, CAD, HF, PHV, HD 
 
 
Pre, peri, post trasnplant 
protocols 
 
Specific for each site 
of transplant 
 
2804 U.S 
Lung Bilateral Lung Transplant; Cystic 
fibrosis, Bronchiectasis, 
Pulmonary 
hypertension,Emphysema 
Pulmonary fibrosis (idoiopathic 
or secondary to scleroderma or 
other disease states) 
 
Single Lung Transplant: 
Emphysema, Pulmonary fibrosis 
(idoiopathic or secondary to 
scleroderma or other disease 
states 
 
Quality of life and cost 
effectiveness 
 
When compared to liver and 
kidney transplants, the long-
term outcomes of LT are 
worse. 
 
Influence of pre-operative 
diagnosis 
 
Influence of the type of 
surgical procedure 
 
Survival benefit 
 
FUNCTIONAL 
OUTCOMES 
 
-Overall quality of 
life during post-Tx 
 
2057 US 
Kidney/Liver DGF-Acute kidney injury 
 
Survival outcomes will vary 
based on disease type, age, 
surgical procedures, etc 
 
Pilot check lists for 
management of ALF 
 
17,878/7127 US 
Pancreas What is pancreatic islet 
transplantation 
Pancreas transplants are most 
often done when a patient also 
receives a new kidney. 
 
MANAGEMENT 
 
Immunosuppressants 
 
 Immunobiology, diagnosis, 
and treatment of rejection 
 
PANCREAS 
TRANSPLANT 
OUTCOMES post-
transplant 
-Rejection status 
-Adverse effects  
Diseases aquired 
after transplants. 
 
228 US 
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Quality Management in a clinical research setting 
 
 The agency that I worked through was the department of quality management, which oversaw all clinical research trials in the 
Hanover medical school. My directors team contained ~ 5 people, and the second team had ~20 people working on different projects 
for the Hanover Medical School in biostatistics. The population they focus on are young pediatric and adult patients that are extremely 
ill and require an organ transplant immediately. The purpose of having a quality management protocol in place, is to make sure all 
clinical trials are being done properly and within the standard operating procedures. The overarching health problem that quality 
management systems deal with are making sure all clinical trials are done within the scope of good clinical practice (GCP), SOP’s and 
within the protocol. Short-term goals are to ensure a safe start to the trial and the risks to the patient are low and not harmful. Long-
term goals for a clinical research trial are to approve the end result as a way to improve/save a life. 
 
 The objectives of my internship were as follows: to create an academic literature review and research Quality Management 
and the type of clinical pathways use in organ transplantation. I was apart of several training sessions on quality management, organ 
transplantation; writing SOP’s, and learning how to write/give an internal audit in a clinical research trial going on at the University 
Hanover medical school. One study I was working on was a new initiative in sharing data with other clinical researchers in the field of 
organ transplantation. I was asked to provide feedback on the subject and how the US would feel about this particular plan. 
 
 
 
 
Stem Cells Multiple diagnosis 
 
Depends on what procedure 
was done. 
 
Different patient 
protocols are 
designed per study. 
N/A for this 
study 
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Evaluation of Data Sharing Initiative (ICMJE) 
 Germany, is currently in the works of creating a system where all clinical trials will be required to responsibly share data 
generated by interventional clinical trials because participants have put themselves at risk. In a growing consensus, many funders 
around the world- foundations, government agencies, and industry, now mandate data sharing (New England Journal of Medicine, 
2016). As a condition of consideration for publications of a clinical trial report in the member journals, the ICMJE proposes to require 
authors to share with others the de-identified individual-patient data (IPD) underlying results presented in the article (including tables, 
figures, and appendices or supplementary material, no later than 6 months after publication (New England Journal of Medicine, 2016). 
Authorizing reliable data sharing is a major endeavor that will shape the fabric o how clinical trials are developed and conducted, and 
how that data will be interpreted (New England Journal of Medicine, 2016). This requirement will revolutionize clinical studies, which 
will save time, money and patients from redoing projects that have already be attempted of done successfully. It also aims, in part, to 
prevent selective publication and selective reporting of research outcomes and to prevent unnecessary duplication of research effort 
(New England Journal of Medicine, 2016). Data sharing will increase confidence and trust in conclusions drawn from clinical trails.    
  
Initiating a Global Virtual Lab 
 Another stride being made in clinical research is the design of a global virtual lab within the United States. Currently, the US 
is working on a Global virtual lab for transplantation as a means of developing and disseminating detailed and rigorous protocols for 
monitoring of alloimmune responses. Global virtual labs are aimed at making standardized testing methods and expertise more 
accessible to the global transplant research community conducting the clinical trials. This new tool will determine the (+/- ) effects that 
have been undetected with biopsies or standard measurements of donor-specific antibodies. This new tool will allow for 
communicating on a global scale with researchers/clinicians around the world. Serveral pros/cons and ethical legalities need to be 
worked out for this to be a functional option. Also, the assessment of outcomes after transplantation is important for several reasons: it 
provides patients with data so that they can make informed decisions about the benefits of transplantation and the success of the 
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transplant unit; it informs commissioners that resources are allocated properly; and it provides clinicians reassurance that results are 
acceptable or, if they are not, provides early warning so that problems can be identified, corrections can be instituted early, and all 
interested parties can be reassured that scarce resources are used fairly. 
› RISK ADJUSTMENT 
› METHODS FOR COMPARING PERFORMANCE 
› WITHIN-CENTER MONITORING TECHNIQUES 
› BETWEEN-CENTER MONITORING TECHNIQUES 
› Cross-Validation Methods 
› Success will have a multitude of reasons and certain organs like the liver, kidney and lungs, will have data showing 
higher trends compared to the heart or pancreas. 
 
Pilot Checklist for Acute Liver Failure: ICU 
In Germany, hospitals are taking a new route in providing excellent patient care before, during and post surgery. An acute liver 
failure checklist was created for the ICU to develop a management strategy to ensure patient safety and efficacy of staff 
management. The checklist can be utilized among multiple provides in different areas. The Initial checklist was developed from 
published guidelines and expert opinion. A total of 81 surveys involving management of 116 patients were done during a pilot 
testing period. The checklist underwent pilot testing at 11 academic liver transplant centers in US and Canada. An anonymous, 
written survey was given to assess overall usability and feasibility of the checklist.  
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Results/Findings 
 Although, there is extensive knowledge in the field of organ transplantation, there are still too many gaps that need to be 
filled. These include death post-transplantation, incidences of infection/diseases and a decrease in long-term survival rates. Shown 
below is an example of the the country leading the way in organ donation on a global health scale. Spain ranks number one, yet for the 
US they’re ranked 6th. Spain has the highest organ donation rate due to outstanding donor detection and organ procurement and all 
other countries are lagging significantly behind. Spain has accomplished something the US will aspire to accomplish in the next 5 
years. 
 
 
 Although strides have been made, there are still several gaps present. For the people to find information on clinical pathways 
hospitals use as guidelines, it was nearly impossible to find. Also, there are still too many challenges face in organ transplantation i.e. 
heart transplantation post-transplant. The discouragement being there is has been no changes in decades and the current shortage of 
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organs is also an issue. The other gap in the field is the lack of patient education for potential problems post-transplantation. Germany 
is currently trying to fix this problem with a quality management system guide in organ transplantation. This QMS guide allows 
doctors to have a set of standards to follow, but after each section in the guide there is a survey of how each doctor viewed its 
feasibility. Shown below is another advancement made in the field of the total maximum time an organ can be transplanted on ice or 
machine. This graph is also being update as we speak. 
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Conclusion and Future Steps 
 
As interest in value-based healthcare continues to drive use of pathways, we need to better understand how they impact patient 
experience, outcomes and expenditures. Organ transplantation is a growing field and heading in the right direction. Currently, there are 
over 300 clinical trials going on in Germany, and quality management systems have a huge role in making sure they are done with 
precision, efficacy and provide the adequate safety to all patients participating. The field of organ transplantation requires more than ever, 
more research on uncovering new strategies in dealing with the growing disparity of organs, as well as, decreasing the risk factors post-
transplantation. Programs will benefit by incorporating focus group interviews for the doctors and patients, and conducting a quantitative 
data analysis on the primary data. All clinical research trials play an important role in providing life to patients in need. Ten years from 
now the goal is to create organs that can be self-sufficient, and not having to rely on organ donation. For the purpose of QM in organ 
transplantation, through observation: A “one size fits all” approach to transition won’t work. We must work with each individual patient’s 
unique physical, cognitive and psychosocial abilities. We need to continue collecting & examining global data on the practices, safety, 
efficacy, quality & epidemiology of allogeneic transplantation, and on ethical issues including living donation, in order to update the WHO 
Guiding Principles on Human Organ Transplantation (WHO, 2010). The use of international relations is still non-existent within clinical 
research. Until these relations are better established the field of organ transplantation will not excel. 
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Application of MPH coursework  
Final Learning Objectives 
 
Goal 1: 
Objectives (S) Activities Start/End Date Who is Responsible Tracking  Measures 
Quality management & 
clinical pathways use in 
organ transplantation 
centers in U.S and EU. 
Literature & research, (), 
compilation of summary 
reports and presentation. 
May 26, 2016 C. Rodrigues & M. 
Barthold 
Checking in every few 
hours and going over each 
step to ensure I was on 
the right track. 
 
Goal 2: 
Objectives (S) Activities Start/End Date Who is Responsible Tracking  Measures 
Standard operating 
procedures, formatting and 
(..) 
Attended training 
sessions 
June 23, 2016 C. Rodrigues & M. 
Barthold 
 
 
Goal 3: 
Objectives (S) Activities Start/End Date Who is Responsible Tracking  Measures 
Working on an Audit for a 
current clinical trial in 
progress 
Working on a moc audit 
to understand the format 
techniques and what 
goes into an audit 
June 27, 2016 C. Rodrigues & M. 
Barthold 
Moc interview 
 
Goal 4: 
Objectives (S) Activities Start/End Date Who is Responsible Tracking  Measures 
Evaluation of data sharing 
Initiative ICMJE 
Literature review  May 26th-June 26th. C. Rodrigues & M. 
Barthold 
Presentation review 
sharing Initiative ICMJE presentation of pros/cons 
with team. 
*   
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Master of Public Health Program 
MPH PROGRAM COMPETENCY INVENTORY  
 
USF MPH Competencies 
 
Proposed Activities 
Number of 
Hours 
(Estimated) 
1.   Assess, monitor, and review the 
health status of populations and 
their related determinants of health 
and illness. 
Internalized data sets of organ 
transplant donors/recipients  
5/hr 
2.   Demonstrate the ability to utilize 
the proper statistical and 
epidemiologic tools to assess 
community needs and program 
outcomes. 
N/A  
3.   Identify and prioritize the key 
dimensions of a public health 
problem by critically assessing 
public health literature utilizing both 
quantitative and qualitative 
sources. 
Created an academic synopsis 
utilizing 15-20 peer-reviewed 
literature on clinical pathways in 
organ transplantation 
10 hours 
4.  Specify approaches for assessing, 
preventing, and controlling 
environmental hazards that pose 
risks to human health and safety. 
N/A  
5.   Apply theoretical constructs of 
social change, health behavior and 
social justice in planning 
community interventions. 
Helped analyze data sets to show 
the trends of social change 
~2-3/hr 
6.  Articulate the relationship between 
health care delivery and financing, 
public health systems, and public 
policy. 
N/A  
7.  Apply evidence-based principles to 
the process of program planning, 
development,  budgeting, 
management, and evaluation in 
public health organizations and 
initiatives. 
I learned how the department of 
QM does their program planning, 
and evaluations within clinical trials. 
2/hrs 
8.  Demonstrate leadership abilities as 
collaborators and coordinators of 
evidence based public health 
projects. 
I collaborated with the director to 
help uncover new evidence-based 
practices in quality management 
5/hr 
9.   Identify and apply ethical, moral, 
and legal principles in all aspects of 
public health practice. 
Uncovered new routes to increasing 
moral standards with my director 
2/hr 
10. Develop public health programs 
and strategies responsive to the 
diverse cultural values and 
traditions of the communities being 
served. 
N/A  
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11. Effectively communicate public 
health messages to a variety of 
audiences from professionals to 
the general public. 
  
12. Advance the mission and core 
values of the University of San 
Francisco. 
  
 
CEPH Core Knowledge Areas 
 
Proposed Activities 
Number of Hours 
(Estimated) 
Biostatistics Was shown multivariable studies 
and how it could improve QM in 
organ transplantation. 
2 
Epidemiology Created new avenues in the route 
of epi and how it could apply new 
treatment avenues. 
3 
Social and Behavioral Sciences Learned all about clinical research 
and organ transplantation, as well 
as, how to apply these new skills. 
3/hr 
Environmental  Health N/A  
Public Health Administration and 
Leadership 
N/A  
Cross- 
Cutting/Interdisciplinary 
Values 
 
Proposed Activities 
Number of Hours 
(Estimated) 
Communication and Informatics Communicated effectively with all 
colleagues and worked on my 
presentation skills. 
10/hr 
Diversity and Culture N/A  
Leadership Worked on creating my own 
synopsis to present to the director 
and board of directors. 
10/hr 
Professionalism Took initiative on my own and 
proposed my own ideas on how 
things could be improved. 
10-15/hr 
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Program Planning N/A  
Public Health Biology N/A  
Systems Thinking Learned discipline in pursuing 
knowledge in a new field (Quality 
management). I also learned how to 
search new data base systems. 
5-10/hr 
 
 
 
